OAS Comment Letters
2024
- October 4, 2024 No comment letter on SA-300 and the Handbook (STC-24-035)
- September 23, 2024 - Comment Letter on SA-10, Oversight of the National Materials Program (RCPD-24-006)
- September 13, 2024 - Comment Letter on Financial Assurance Requirements for Disposition of Category 1-3 Byproduct Material (RCPD-24-007)
- Fusion Systems (RCPD-24-004) Comment Letters on Draft Proposed Rule: Regulatory Framework for Fusion Systems
- July 12, 2024 - No Comment Letter, support of Alternative 2, Draft Rulemaking Plan: Physical Protection of Radioactive Materials (RCPD-24-005)
- June 10, 2024 Comment letter on the Draft Guidance for the Implementation of 10 CFR 35 Training and Experience Requirements (RCPD-24-002)
- June 10, 2024 Comment letter on the Draft Proposed Rule: Reporting Nuclear Medicine Injection Extravasations as Medical Events (RCPD-24-003)
- May 17, 2024 Comment on the Interim Procedure SA-500, Jurisdictional Determinations (STC-23-076)
- May 17, 2024 No comment letter on the Proposed Rule: Advance Tribal Notification of Category 1 Quantities of Radioactive Material and the associated guidance (STC-24-019)
- March 14, 2024 OAS No Comment Letter on Draft Proposed Rule: Integrated Low-Level Radioactive Waste Disposal (RCPD-24-001)
- March 4, 2024 OAS Comment Letter on RCPD-23-006, Draft Licensing Guidance for the Akesis Galaxy RTi and the LV
- Liberty Vision Corporation Model 1 Yttrium-90 Disc and iWand® Ophthalmic System
- January 18, 2024 OAS Comment Letter on Draft ABK Biomedical, Inc. Eye90 Microspheres® Manual Brachytherapy Licensing Guidance (RCPD-23-005)
2023
- December 14, 2023 OAS Comment Letter on the regulatory basis for the rulemaking to establish requirements for rubidium-82 generators, emerging technologies, and other medical use of byproduct material (STC-23-049, federal register notice docket number NRC-2018-0297)
- September 1, 2023 OAS Comment Letter to NRC on proposed rule Reporting Nuclear Medicine Injection Extravasations at Medical Events (STC-23-033 and STC-23-052)
- April 4, 2023 OAS Comment Letters on the Nuclear Regulatory Commission (NRC) interim state agreement (SA) procedure, SA-802, Standing Committee for Reviewing Emerging Medical Technologies (STC-22-059)
- February 23, 2023 OAS Comment Letter on STC-22-033, Interim Procedure SA-300, Reporting Material Events, and the Interim Handbook on Nuclear Material Event Reporting for the Agreement States. and STC-22-065, Revised Interim Handbook on Nuclear Material Event Reporting for the Agreement States
2022
- December 1, 2022 OAS Comment Letter to NRC on preliminary regulatory basis for the 10 CFR Part 35 rulemaking to establish requirements for rubidium-82 generators and emerging medical technologies (RCPD-22-010)
- October 18, 2022 OAS Submission of Potential License Conditions for review and concurrence - Category 3 quantities of radioactive materials after the NRC completes the rulemaking process, but before an Agreement State is able to complete their own regulatory changes
- June 17, 2022 OAS Comment Letter to NRC Draft Commission paper: “Rulemaking Plan on Release of Animals Receiving
- Treatment Containing Byproduct Material.” (RCPD-22-002)
- February 11, 2022 OAS Comments to USEPA regarding Multi-Agency Radiation Survey and Site Investigation Manual (MARSSIM), Revision 2
- January 31, 2022 OAS Comment Letter to NRC on the draft licensing guidance for the “Superficial Manual Brachytherapy CivaDermTM Device” (RCPD-21-015)
2021
- December 21, 2021 OAS Comment Letter on NRC's Regulatory Basis for the Decommissioning Financial Assurance for Sealed and
- Unsealed Radioactive Materials (RCPD-21-008)
- December 21, 2021 OAS Comment Letter on NRC's Draft Commission Paper: “Petition for Rulemaking and Rulemaking Plan on
- Reporting Nuclear Medicine Injection Extravasations as Medical Events” (RCPD-21-012).
- November 19, 2021 OAS Comment Letter to NRC on the draft of licensing guidance for Alpha Tau’s Alpha DaRT TM (Diffusing Alphaemitters Radiation Therapy), prepared under Title 10 of the Code of the Federal Regulations (CFR), Section
- 35.1000, “Other medical uses of byproduct material or radiation from byproduct material.” (RCPD-21-009)
- November 1, 2021 OAS Comment Letter on Draft Regulatory Guide 8.39, Release of Patients Administered Radioactive
- Materials, Revision 2 (RG 8.39) (RCPD-21-007)
- October 6, 2021 OAS Comment Letter on Inspection Procedures associated with Inspection Manual Chapter (IMC) 2800
- “Materials Inspection Program” (RCPD-21-006)
- July 1, 2021 OAS Comment Letter on NRC's “Notice of Interpretation on Industrial Radiographic Operations at Temporary Radiography Jobsites and an Agreement State Compatibility Category Change; Request for Comments” (STC-21-032).
- January 15, 2021 OAS Comment Letter on Revised State Agreement Procedure (SA), Periodic Meetings Between IMPEP Reviews (STC-20-077).
2020
- November 30, 2020 OAS Comment Letter to NRC regarding STC-20-6-066, "Petition for Rulemaking That Would Require Reporting of Certain Nuclear Medicine Injection Extravasations as Medical Events"
- November 20, 2020 OAS Comment Letter to NRC regarding NRC's draft SECY paper "Rulemaking Plan to Codify Req. for RB-82 Generators and Emerging Medical Technologies"
- November 9, 2020 OAS Comment Letter to NRC regarding NUREG 1757, Vol 1, Rev 3
- October 26, 2020 OAS Comment Letter to NRC regarding Exubrion revised TER
- September 23, 2020 OAS Comment Letter to NRC regarding the draft TI on IMPEP
- August 14, 2020 OAS Comment Letter to NRC regarding Exubrion
- July 21, 2020 OAS Letter to NRC regarding Harmonization of Transportation Safety Regulations with IAEA Standards
- July 20, 2020 OAS Letter to NRC regarding transfer of VLLW to Exempt Persons for Disposal
- February 26, 2020 OAS Letter to Commissioners
- January 15, 2020 OAS Board letter to NRC concerning previously submitted Y-90 Licensing Guidance Letter
2017 - 2019
- November 19, 2019 OAS comment letter regarding the regulatory basis for Disposal of Greater-than-Class C (GTCC) and Transuranic Waste
- November 12, 2019 OAS comment letter regarding the draft Revision to Inspection Manual Chapter (IMC) 2800, "Materials Inspection Program"
- October 17, 2019 OAS comment letter regarding the draft SECY paper "Training and Experience Requirements for Administration of Radiopharmaceuticals requiring a Written Directive” (RCPD-19-011)
- September 26, 2019 OAS comment letter regarding draft Regulatory Guide 8.39 Release of Patients Administered Radioactive Material
- September 16, 2019 OAS comment letter regarding draft Revision 1 of the Northstar Radiogenix Molybdenum-99/Technetium-99M Generator System Licensing Guidance
- July 3, 2019 OAS comment letter regarding Federal Register Notice of May 2, 2019 (84 FRN 18874)
- June 24, 2019 OAS comment letter regarding Draft Y-90 Microsphere Brachytherapy Licensing Guidance (RCPD-19-006)
- March 11, 2019 OAS comment letter regarding Oversight of the National Materials Program SA-10
- January 29, 2019 OAS comment letter regarding T&E requirements for authorized users
- November 15, 2018 OAS comment letter regarding Ge Ga Licensing Guidance
- October 9, 2018 Center for Medicare & Medicaid Services regarding CLIA certificate
- July 16, 2018 OAS comment letter regarding staff evaluation of training and experience for administering radiopharmaceuticals
- May 15, 2018 OAS comment letter regarding NRC Revision to Management Directive 5.6
- May 15, 2018 US NRC Federal Register Notice and public meeting regarding the very low-level radioactive waste scoping study and greater than class C waste
- May 4, 2018 Opportunity to comment on a proposal to limit the number of special management review board meetings
- February 8, 2018 Opportunity to comment on Y-90 microsphere brachytherapy sources and devices
- December 18, 2017 Opportunity to comment on draft guidance for alternative disposal requests
- November 2, 2017 Opportunity to comment on draft NRC staff's evaluation of the NRC patient release program
- September 20, 2017 Opportunity to comment on draft revision to NMSS procedures MD 5.7 and SA-1001
- September 5, 2017 Opportunity to comment on draft revision to NMSS procedure MD 5.9
- August 3, 2017 Opportunity to comment of draft RIS regarding NTAS and protective measures for the physical protection of category 1 and 2 sources
- May 31, 2017 Opportunity comment on draft revision to NMSS SA-116
- May 15, 2017 Opportunity to comment on draft NRC Inspection Manual Chapter 2800
- March 31, 2017 Opportunity to comment on draft NUREG 1556, vol. 9, revision 3
- March 24, 2017 Opportunity to comment on draft NUREG 1556, vol. 13, revision 2
- March 24, 2017 Opportunity to comment on draft NUREG 1556, vol. 8, rev. 1
- March 17, 2017 Opportunity to comment on the determination to revise processes governing category 3 sources
- March 8, 2017 Opportunity to comment on draft NUREG 1556, vol. 17, rev. 1
- March 8, 2017 Opportunity to comment on draft NUREG 1556, vol. 21, rev. 1